Rxivist logo

Author: Kosuke Yusa

  • Most recently observed institution: Kyoto University

Rankings

  • All-time downloads: 18,561 (rank: 3,463 out of 404,161)
  • Categories:
    • bioinformatics: 699 (rank: 15,549 (tie) out of 34,272)
    • cancer biology: 9,223 (rank: 162 out of 28,183)
    • cell biology: 1,322 (rank: 3,633 (tie) out of 30,511)
    • genomics: 4,045 (rank: 4,960 (tie) out of 42,763)
    • immunology: 3,272 (rank: 1,271 (tie) out of 23,479)

Downloads per author, site-wide

Preprints

Prioritisation of oncology therapeutic targets using CRISPR-Cas9 screening

cancer biology more details view paper
  • Downloaded 3,848 times
  • Download rankings, all-time:
    • Site-wide: 1,294 out of 94,912
    • In cancer biology: 33 out of 3,367
  • Year to date:
    • Site-wide: 12,298 out of 94,912
  • Since beginning of last month:
    • Site-wide: 13,628 out of 94,912

Genome-wide CRISPR screens in T helper cells reveal pervasive cross-talk between activation and differentiation

immunology more details view paper
  • Downloaded 3,272 times
  • Download rankings, all-time:
    • Site-wide: 1,700 out of 94,912
    • In immunology: 56 out of 2,857
  • Year to date:
    • Site-wide: 23,633 out of 94,912
  • Since beginning of last month:
    • Site-wide: 27,464 out of 94,912

Agreement between two large pan-cancer CRISPR-Cas9 gene dependency datasets

cancer biology more details view paper
  • Downloaded 1,906 times
  • Download rankings, all-time:
    • Site-wide: 4,200 out of 94,912
    • In cancer biology: 95 out of 3,367
  • Year to date:
    • Site-wide: 18,690 out of 94,912
  • Since beginning of last month:
    • Site-wide: 20,332 out of 94,912

Minimal genome-wide human CRISPR-Cas9 library

genomics more details view paper
  • Downloaded 1,692 times
  • Download rankings, all-time:
    • Site-wide: 5,117 out of 94,912
    • In genomics: 830 out of 5,955
  • Year to date:
    • Site-wide: 1,864 out of 94,912
  • Since beginning of last month:
    • Site-wide: 7,831 out of 94,912

JACKS: joint analysis of CRISPR/Cas9 knock-out screens

genomics more details view paper
  • Downloaded 1,601 times
  • Download rankings, all-time:
    • Site-wide: 5,619 out of 94,912
    • In genomics: 909 out of 5,955
  • Year to date:
    • Site-wide: 52,797 out of 94,912
  • Since beginning of last month:
    • Site-wide: 77,799 out of 94,912

Genome-wide and high-density CRISPR-Cas9 screens identify point mutations in PARP1 causing PARP inhibitor resistance

cancer biology more details view paper
  • Downloaded 1,444 times
  • Download rankings, all-time:
    • Site-wide: 6,657 out of 94,912
    • In cancer biology: 175 out of 3,367
  • Year to date:
    • Site-wide: 29,987 out of 94,912
  • Since beginning of last month:
    • Site-wide: 18,085 out of 94,912

ATM orchestrates the DNA-damage response to counter toxic non-homologous end-joining at broken replication forks

cell biology more details view paper
  • Downloaded 1,322 times
  • Download rankings, all-time:
    • Site-wide: 7,722 out of 94,912
    • In cell biology: 267 out of 4,894
  • Year to date:
    • Site-wide: 43,498 out of 94,912
  • Since beginning of last month:
    • Site-wide: 61,583 out of 94,912

Functional linkage of gene fusions to cancer cell fitness assessed by pharmacological and CRISPR/Cas9 screening

cancer biology more details view paper
  • Downloaded 1,055 times
  • Download rankings, all-time:
    • Site-wide: 11,292 out of 94,912
    • In cancer biology: 315 out of 3,367
  • Year to date:
    • Site-wide: 25,883 out of 94,912
  • Since beginning of last month:
    • Site-wide: 27,670 out of 94,912

Tandem duplications lead to loss of fitness effects in CRISPR-Cas9 data

genomics more details view paper
  • Downloaded 752 times
  • Download rankings, all-time:
    • Site-wide: 19,140 out of 94,912
    • In genomics: 2,296 out of 5,955
  • Year to date:
    • Site-wide: 58,012 out of 94,912
  • Since beginning of last month:
    • Site-wide: 55,402 out of 94,912

A screen for combination therapies in BRAF/NRAS wild type melanoma identifies nilotinib plus MEK inhibitor as a synergistic combination

cancer biology more details view paper
  • Downloaded 726 times
  • Download rankings, all-time:
    • Site-wide: 20,126 out of 94,912
    • In cancer biology: 605 out of 3,367
  • Year to date:
    • Site-wide: 43,481 out of 94,912
  • Since beginning of last month:
    • Site-wide: 57,874 out of 94,912

Unsupervised correction of gene-independent cell responses to CRISPR-Cas9 targeting

bioinformatics more details view paper
  • Downloaded 699 times
  • Download rankings, all-time:
    • Site-wide: 21,299 out of 94,912
    • In bioinformatics: 3,050 out of 8,837
  • Year to date:
    • Site-wide: 65,005 out of 94,912
  • Since beginning of last month:
    • Site-wide: 71,844 out of 94,912

KAT7 is a therapeutic vulnerability of MLL-rearranged acute myeloid leukemia

cancer biology more details view paper
  • Downloaded 244 times
  • Download rankings, all-time:
    • Site-wide: 65,556 out of 94,912
    • In cancer biology: 2,156 out of 3,367
  • Year to date:
    • Site-wide: 16,181 out of 94,912
  • Since beginning of last month:
    • Site-wide: 11,295 out of 94,912

PanLingua

Sign up for the Rxivist weekly newsletter! (Click here for more details.)


News